Streamlining Preventive Health for Patients with IBD Through Effective Care Models, Evidence-based Guidelines, and Patient EngagementPremiere Date: Thursday, March 28, 2019
This activity offers CE credit for:%>
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, December 31, 2020
|Miguel Regueiro, MD, AGAF, FACG, FACP (Moderator)
Professor and Chair
Department of Gastroenterology, Hepatology & Nutrition
The Pier C. and Renee A. Borra Family Endowed Chair in Gastroenterology and Hepatology
|Baljit Bal, MD
Department of Internal Medicine and Geriatrics
|Gil Y. Melmed, MD, MS
Co-Director, Clinical Inflammatory Bowel Disease
Division of Gastroenterology/Department of Medicine
Cedars-Sinai Medical Center
Los Angeles, CA
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA
|Eva M. Szigethy, MD, PhD, FACG
Professor of Psychiatry, Medicine & Pediatrics
Director, Behavioral Health within the Chief Medical and Scientific Office
Director, IBD Total Care Medical Home
University of Pittsburgh Medical Center
The Cleveland Clinic estimates that less than 20% of patients with IBD seen in their Digestive Disease & Surgery Institute have received appropriate immunization and preventative services that align with national guidelines and recommendations. Education is an important component for creating a roadmap and gaining buy-in among clinicians to implement change in practice. Educational interventions to both health care professionals (HCPs) and patients as part of the project to improve patient health, vaccination rates, and preventive services are essential for these changes.
Outside of the clinic, digital health coaching presents additional opportunities to supplement and support patient education and reinforce the need to complete all necessary vaccinations among a group of 100 patients. Patient-reported outcomes and feedback will be collected to assess improvements in vaccination and preventive health literacy, communication with providers, and shared decision-making.
In this CME Outfitters Live and On Demand, expert faculty will discuss best practices for vaccinations and preventive services among individuals with IBD along with resources that will help clinicians to truly engage patients.
At the end of this CE activity, participants should be able to:
- Integrate recommended immunizations for patients with IBD into clinical practice.
- Implement guideline-based methods for preventive health maintenance among patients with IBD.
- Employ successful approaches to coordinated patient-centered care for patients with IBD, including the establishment of an IBD medical home.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Identify recommended immunizations for patients with IBD into clinical practice.
- Explain guideline-based methods for preventative health maintenance among patients with IBD.
- Describe successful approaches to coordinated patient-centered care for patients with IBD, including the establishment of an IBD medical home.
Supported by educational grants from Pfizer Inc., Salix Pharmaceuticals, Inc., and Takeda Pharmaceuticals U.S.A., Inc.
Gastroenterologists, primary care physicians, physician assistants, nurse practitioners, and pharmacists.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.
Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Regueiro reports that he receives research support from AbbVie Inc.; Janssen Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc. He receives unrestricted educational grants from Abbvie Inc.; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Salix Pharmaceuticals; Shire; Takeda Pharmaceuticals U.S.A., Inc.; UCB, Inc. He is on advisory boards and a consultant for AbbVie Inc.; Allergan; Amgen Inc.; Celgene Corporation; Janssen Pharmaceuticals, Inc.; Miraca Laboratories; Pfizer Inc.; Seres Therapeutics; Takeda Pharmaceuticals U.S.A., Inc.; UCB, Inc.
Dr. Bal has not disclosures to report.
Dr. Bondar has no disclosures to report.
Ms. Cavagnaro has no disclosures to report.
Dr. Leonard has no disclosures to report.
Dr. Melmed reports that he receives grants and research support from Pfizer Inc. He is a consultant for AbbVie Inc.; Celgene Corporation; Janssen Pharmaceuticals, Inc.; Medtronic; Pfizer Inc.; Samsung Bioepis; Takeda Pharmaceuticals U.S.A., Inc.
Dr. Rizk has no disclosures to report.
Ms. Sullivan has no disclosures to report.
Dr. Szigethy reports she receives grants from National Institutes of Health (NIH); Patient-Centered Outcomes Research Institute (PCORI). She also serves as a consultant for Cartesian Solutions, Inc. and receives Royalties from APPI.
Jeffrey Helfand, DO (Peer Reviewer) has no disclosures to report.
Ms. Ochoa, RPh (Peer Reviewer) has no disclosures to report.
Kate Nelson, PHD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).